Psychosocial Teleassistance Programme for Adults With Spina Bifida
This clinical trial assesses the effect of a telecare psychosocial intervention designed for adults with spina bifida. The intervention consists of 10 weekly 1.5-hour group sessions, followed by two 3-month follow-up sessions. Each group will consist of 6 to 7 individuals. The intervention is aimed at strengthening aspects of self-concept, self-esteem, social skills and aims at a reduction of symptomatology and a general improvement of psychological well-being.
Conditions studied
Spina Bifida, Self Esteem, Quality of Life (QOL), Self Concept, Anxiety, Depression, Interpersonal Needs
About this study
This clinical trial assesses the effect of a telecare psychosocial intervention designed for adults with spina bifida. The intervention consists of 10 weekly 1.5-hour group sessions, followed by two 3-month follow-up sessions. Each group will consist of 6 to 7 individuals. The intervention is aimed at strengthening aspects of self-concept, self-esteem, social skills and aims at a reduction of symptomatology and a general improvement of psychological well-being.
Interventions
- Behavioral: Psychosocial teleassistance intervention — The teleassistance psychosocial intervention involves 10 weekly 90-minute group sessions, with each group comprising 6 to 7 participants. These sessions are designed to enhance self-concept, self-esteem and social skills, reduce symptoms, and improve overall psychological well-being. Two follow-up sessions will be provided three months after the main program concludes.
Primary outcomes
- Quality of life - The World Health Organization WHOQOL-BREF Quality of Life Assessment (3 months after the intervention)
- Anxiety and depression - The Hospital Anxiety and Depression Scale (3 months after the intervention)
- Depression - The Patient Health Questionnaire (3 months after the intervention)
- Self-esteem - The Rosenberg Self-Esteem Scale (3 months after the intervention)
- Self-Concept - Self-Concept Questionnaire Form-5 (3 months after the intervention)
Eligibility information
Study locations
- University of Deusto, Bilbao, Bizkaia 48007 Spain
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.